Doctors Food Leads Physicians 
World of DTC Marketing
MARCH 23, 2022
The program was codified into law under the Food and Drug Safety and Innovation Act (FDASIA) in 2012. Of course, they should, but in the end, it’s going to come down to trust in their doctor and the FDA. Do patients care? The answer to that would be “no.” The post Do patients care about accelerated approval drugs?
PM360
APRIL 25, 2023
In terms of pulling, our communities team will go out and try to identify who are the leading KOLs from a space and invite them to jump on a Zoom call to explain how the platform works, why they should be excited about it, why they should buy into the process, and see if they are interested in producing content.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
World of DTC Marketing
MAY 11, 2021
As the oldest millennials start to hit 40, many are finding themselves coping with chronic health conditions — more so than previous generations, according to some recent research and it’s going to lead to higher healthcare costs for ALL of us. According to a study, few Americans have a lifestyle that is considered healthy.
World of DTC Marketing
AUGUST 16, 2022
While some medical issues cause obesity, the most significant cause is eating the wrong foods and lack of exercise. A New York Times article said, “Poor diet is the leading cause of mortality in the U.S.” These people hand cards, telling physicians not to weigh them to nurses. It leads to a lack of accountability.
PM360
AUGUST 9, 2022
Doctor Docs: Oncologists React to ASCO Educational Material. Sermo , a physician-first online community, found the tracks at ASCO that oncologists felt were the most transformative to be breast cancer (58%), lung cancer (34%), and developmental therapeutics—molecularly targeted agents and tumor biology (32%).
Pharmaceutical Technology
AUGUST 12, 2022
In the lead-up to a critical meeting that will influence the approval of a new drug for amyotrophic lateral sclerosis (ALS), the US Food and Drug Administration (FDA) has detailed its plans to advance rare neurodegenerative disease research. In the US, most physicians can only spend a day a week, which isn’t efficient, she says. “We
European Pharmaceutical Review
MARCH 4, 2024
Indeed, in 2022, biologics constituted 40 percent of all US Food and Drug Administration (FDA) approved drugs, projecting a compound annual growth rate (CAGR) of 9.5 These actions occur at both the delivery site and other systemic locations, thereby promoting an immunogenic response that leads to cancer cell death.
Expert insights. Personalized for you.
200 
Let's personalize your content